Show simple item record

dc.contributor.authorSihlbom, Carina
dc.date.accessioned2006-12-01T07:18:41Z
dc.date.available2006-12-01T07:18:41Z
dc.date.issued2006-12-01T07:18:41Z
dc.identifier.isbn91-628-7001-7
dc.identifier.isbn978-91-628-7001-0
dc.identifier.urihttp://hdl.handle.net/2077/774
dc.description.abstractBiological processes involve changes at the protein level. Proteomics aims to determine protein changes from a normal state, to measure for instance recovery or disease progression. Mass spectrometry is the most important tool for identification of proteins and determination of post-translational modifications such as glycosylation. Glycoproteins are found to be altered in patients with Alzheimer's disease (AD). Changes in glycosylation levels were quantified after gel separation and glycan structures were determined with mass spectrometry. Protein quantification with mass spectrometric methods is based on stable isotope labeling of proteins. Quantitative proteomics was applied to assess protein expression levels with mass spectrometry in the murine brain after specific neurosurgery to study regenerative processes. In order to compare glycosylated proteins in cerebrospinal fluid (CSF) from AD patients with control individuals, albumin depleted CSF proteins were separated with narrow pH-range two-dimensional gel electrophoresis followed by multiple staining for quantification of glycoprotein isoforms. Structural site-specific analysis of glycopeptides was performed with Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS). A decreased glycosylation level for alpha-1-antitrypsin was found in AD patients. No specific glycoform of the studied proteins could be assigned to AD, emphasizing that further studies should include a larger subject group and cover proteins in various pH intervals. Knowledge of glycoprotein structures may assist in elucidation of the pathogenic process. In order to study proteins involved in the response of astrocytes and regenerative processes after neurotrauma, a quantitative mass spectrometric method was developed. Astrocytes react to neurotrauma by becoming reactive (reactive gliosis). Mice lacking the intermediate filament proteins GFAP and vimentin (GFAP–/–Vim–/–) show attenuated reactive gliosis and enhanced regeneration after neurotrauma. Culture-derived isotope tags (CDIT) and nano-liquid chromatography FT-ICR MS showed that the 14-3-3 epsilon isoform was upregulated in denervated hippocampus in wildtype mice, while this response was attenuated in GFAP–/–Vim–/– mice. Thus, the increase in 14-3-3 epsilon expression in neurotrauma appears to be linked to astrocyte activation. We demonstrated that the CDIT-based quantitative proteomic method is a highly useful approach to assess isoform-specific protein expression levels in defined parts of the brain after neurosurgical interventions.eng
dc.format.extent110730 bytes
dc.format.extent2579895 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.language.isoengeng
dc.relation.haspartI. Glycoproteomics of cerebrospinal fluid in neurodegenerative disease. Sihlbom Carina, Davidsson Pia, Emmett Mark R., Marshall Alan G. and Nilsson Carol L. International Journal of Mass Spectrometry (2004) 234, 145-152.eng
dc.relation.haspartII. Prefractionation of cerebrospinal fluid to enhance glycoprotein concentration prior to structural determination with FT-ICR mass spectrometry. Sihlbom Carina, Davidsson Pia and Nilsson Carol L. Journal of Proteome Research (2005) 4, 2294-2301.eng
dc.relation.haspartIII. Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer’s disease patients and healthy individuals. Sihlbom Carina, Davidsson Pia, Sjögren Magnus, Wahlund Lars-Olof and Nilsson Carol L. Submitted manuscripteng
dc.relation.haspartIV. 14-3-3 expression in denervated hippocampus after entorhinal cortex lesion assessed by culture-derived isotope tags in quantitative proteomics. Sihlbom Carina, Wilhelmsson Ulrika, Li Lizhen, Nilsson Carol L. and Pekny Milos. Submitted manuscripteng
dc.subjectglycoproteomicseng
dc.subjectquantitative proteomicseng
dc.subjectglycoproteineng
dc.subjectprotein quantificationeng
dc.subjectglycosylationeng
dc.subjectFourier transform ion cyclotron mass spectrometryeng
dc.subjectcerebrospinal fluideng
dc.subjectAlzheimer's diseaseeng
dc.subjectneurodegenerationeng
dc.subjectneuroregenerationeng
dc.subjecthippocampuseng
dc.subjectastrocyteseng
dc.subjectbrain injuryeng
dc.subject14-3-3 proteineng
dc.subjectisoformeng
dc.titleMass spectrometry for comparative proteomics of degenerative and regenerative processes in the braineng
dc.typetexteng
dc.type.svepDoctoral thesiseng
dc.identifier.doihttp://dx.doi.org/10.1016/j.ijms.2004.02.016eng
dc.identifier.doihttp://dx.doi.org/10.1021/pr050210geng
dc.gup.mailcarina.sihlbom@medkem.gu.seeng
dc.type.degreeDoctor of Philosophy (Medicine)eng
dc.gup.defenceOnsdagen den 6 december 2006 kl. 13.00. Föreläsningssal Ragnar Sandberg, Medicinaregatan 7A, Göteborgeng
dc.gup.originGöteborg University. Sahlgrenska Academyeng
dc.gup.departmentInst of Biomedicine. Dept of Medical Biochemistry and Cell Biologyeng
dc.gup.dissdb-fakultetSA


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record